XML 33 R20.htm IDEA: XBRL DOCUMENT
v3.25.3

EARNINGS PER SHARE | 9 Months Ended
--- | ---
Sep. 30, 2025
Earnings Per Share |
Earnings per share | NOTE 13 – EARNINGS PER SHARE ​ The following table illustrates the computation of basic and diluted earnings per share for the three and nine months ended September 30, 2025 and 2024 (in thousands, except per share data): ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | For the Three Months Ended | ​ | For the Nine Months Ended
​ | ​ | September 30, | ​ | September 30,
​ |  | 2025 |  | 2024 |  | 2025 |  | 2024
Numerator (basic and diluted): |  | ​ |  |  | ​ |  |  | ​ |  |  | ​ |
Net income | ​ | $ | 725,896 | ​ | $ | 665,464 | ​ | $ | 1,932,976 | ​ | $ | 1,835,550
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Denominator: | ​ |  |  | ​ |  |  | ​ |  |  | ​ |  |
Weighted-average common shares outstanding – basic | ​ |  | 848,292 | ​ |  | 869,971 | ​ |  | 853,909 | ​ |  | 878,442
Effect of stock options (1) | ​ |  | 4,412 | ​ |  | 5,052 | ​ |  | 4,543 | ​ |  | 5,693
Weighted-average common shares outstanding – assuming dilution | ​ |  | 852,704 | ​ |  | 875,023 | ​ |  | 858,452 | ​ |  | 884,135
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Earnings per share: | ​ |  |  | ​ |  |  | ​ |  |  | ​ |  |
Earnings per share-basic | ​ | $ | 0.86 | ​ | $ | 0.76 | ​ | $ | 2.26 | ​ | $ | 2.09
Earnings per share-assuming dilution | ​ | $ | 0.85 | ​ | $ | 0.76 | ​ | $ | 2.25 | ​ | $ | 2.08
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Antidilutive potential common shares not included in the calculation of diluted earnings per share: | ​ |  |  | ​ |  |  | ​ |  |  | ​ |  |
Stock options (1) | ​ |  | 801 | ​ |  | 1,385 | ​ |  | 1,155 | ​ |  | 1,723
Weighted-average exercise price per share of antidilutive stock options (1) | ​ | $ | 88.18 | ​ | $ | 68.46 | ​ | $ | 83.14 | ​ | $ | 65.17
(1) | See Note 12 for further information concerning the terms of the Company’s share-based compensation plans.
​ For the three and nine months ended September 30, 2025 and 2024, the computation of diluted earnings per share did not include certain securities. These securities represent underlying stock options not included in the computation of diluted earnings per share, because the inclusion of such equity awards would have been antidilutive. ​ See Note 9 for information concerning the Company’s subsequent share repurchases.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/260/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-3 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration